LupinLife, the consumer healthcare division of global pharmaceutical giant Lupin Limited, announced a significant entry into the Indian liquid laxative market with the launch of Softovac Liquifibre. This innovative product marks a new chapter in digestive health solutions, offering a 100% Ayurvedic liquid laxative formulated with natural actives like Isabgol fibre, Sonamukhi, Harad, Mulethi, Saunf, […]
Global pharmaceutical giant, Lupin Limited, has made a significant stride in healthcare innovation with the launch of its state-of-the-art Regional Reference Laboratory in Chennai, Tamil Nadu. This pivotal expansion aligns with Lupin Diagnostics’ commitment to offering accessible, affordable, and high-quality diagnostic healthcare services in South India. The Chennai facility joins Lupin Diagnostics’ extensive network, which […]
Global pharmaceutical company Lupin Limited has announced its receipt of approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Allopurinol Tablets USP, 100 mg and 300 mg. This approval enables Lupin to market a generic equivalent to Zyloprim Tablets, 100 mg and 300 mg, of […]
Global pharmaceutical giant Lupin Limited has made a significant entry into the U.S. contraceptive market with the launch of Turqoz (Norgestrel and Ethinyl Estradiol) Tablets USP, 0.3 mg/0.03 mg. This follows the company’s successful receipt of approval from the United States Food and Drug Administration (U.S. FDA). Turqoz: A Generic Equivalent to Lo/Ovral-28 Turqoz is […]
Global pharmaceutical leader, Lupin Limited, announced its significant achievement of receiving tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Canagliflozin Tablets, both 100 mg and 300 mg. This approval allows Lupin to market a generic equivalent of Invokana Tablets, manufactured by Janssen Pharmaceuticals, […]
Global pharmaceutical giant Lupin Limited announced its receipt of approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Pitavastatin Tablets in 1 mg, 2 mg, and 4 mg dosages. These tablets are set to be a generic equivalent of Livalo Tablets by Kowa Company Limited, […]
Lupin Limited, a global pharma major, has announced its receipt of approval from the United States Food and Drug Administration (U.S. FDA) for Ganirelix Acetate Injection. This milestone authorizes Lupin to market a generic equivalent to the reference listed drug (RLD) of Ganirelix Acetate Injection, 250 mcg/0.5 mL, originally of Organon USA LLC. Lupin’s First […]
In a significant move within the pharmaceutical industry, Zydus Lifesciences Limited, renowned for its global lifesciences innovations, and Lupin Limited, a leading global pharma entity, have officially declared their collaboration. The two companies have established a licensing and supply agreement for the co-marketing of Saroglitazar Mg, a pivotal medication for the management of Non-Alcoholic Fatty […]
Lupin Limited, a recognized global pharmaceutical powerhouse, proudly announced its receipt of the much-anticipated approval from the US Food and Drug Administration (FDA). This authorization paves the way for its Abbreviated New Drug Application concerning Fluconazole Tablets USP in varying strengths: 50 mg, 100 mg, 150 mg, and 200 mg. These tablets are designed to […]
In a significant stride for global pharmaceuticals, Lupin Limited has garnered tentative approval from the United States Food and Drug Administration (U.S. FDA) to introduce its generic version of Apalutamide Tablets, 60 mg, echoing the renowned Erleada Tablets by Janssen Biotech, Inc. With an aim to tap into the vast US market, Lupin’s Abbreviated New […]